AURA, a division of Intas Pharmaceuticals based in Ahmedabad, Gujarat, achieved a remarkable milestone in the field of gastroenterology. By organising the world’s largest real-world survey on the Rabeprazole + Levosulpiride combination for the treatment of Gastroesophageal Reflux Disease (GERD), AURA brought together an unprecedented network of 3,126 doctors in a unified scientific effort.
GERD, a condition marked by persistent acidity, heartburn, and reflux, affects millions and significantly impacts daily life. While clinical trials provide structured insights, real-world data reflects the realities of everyday medical practicehow treatments perform across diverse patient profiles, varying lifestyles, and practical healthcare settings. Recognising this need, AURA initiated a nationwide collaborative survey designed to capture authentic clinical experiences directly from practicing physicians.
The scale of participation was extraordinary. Over three thousand doctors contributed their observations, treatment patterns, and patient outcomes, creating a comprehensive dataset that mirrors the ground realities of GERD management. This massive engagement not only demonstrates the medical community’s trust in the initiative but also highlights a shared commitment to refining patient care through evidence-based insights.Behind the numbers lies meticulous planning, coordination, and a vision to bridge research with real-world application. By focusing on the Rabeprazole + Levosulpiride combination, AURA sought to better understand its therapeutic effectiveness and practical relevance in managing GERD symptoms.
This landmark initiative reinforces Intas Pharmaceuticals’ dedication to advancing healthcare through collaborative research and meaningful medical engagement. More than a survey, it represents a step forward in strengthening clinical knowledge, empowering physicians, and ultimately improving the quality of life for patients living with GERD.Through innovation and large-scale collaboration, AURA has set a new global benchmark in real-world medical research.
